Tonix Pharmaceuticals Holding (TNXP) Return on Invested Capital (ROIC)
Market Cap: $83.86M
Avg Volume: 1.96M
Industry: Biotechnology
Sector: Healthcare
Return on Invested Capital (ROIC) Summary
Tonix Pharmaceuticals Holding's ROIC measures how effectively the company uses its invested capital to generate profits:
- Annual: -85.66%
- Quarterly: -19.42%
- TTM: -102.21%
What is ROIC?
Return on Invested Capital (ROIC) measures how effectively a company uses its capital from debt and equity to generate profits. ROIC is a useful metric for comparing the efficiency of capital allocation between different companies or across time periods within the same company. A higher ROIC indicates a more efficient use of capital.
Related Metrics
Other important metrics to assess Tonix Pharmaceuticals Holding's profitability include:
- ROE (Return on Equity) - measures the return generated on shareholders' equity:
- Annual: -110.55%
- Quarterly: -19.15%
- TTM: -163.95%
- ROA (Return on Assets) - measures the return generated on the company's assets:
- Annual: -75.53%
- Quarterly: -14.96%
- TTM: -142.38%
These metrics provide insights into Tonix Pharmaceuticals Holding's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROIC
-85.66%
Quarterly ROIC
-19.42%
TTM ROIC
-102.21%
Tonix Pharmaceuticals Holding Historical ROIC
Historical ROE
Historical ROA
Tonix Pharmaceuticals Holding Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | ROIC | ROE | ROA |
|---|---|---|---|
| 2023 | -85.66% | -110.55% | -75.53% |
| 2022 | -56.25% | -56.41% | -51.79% |
| 2021 | -41.99% | -42.19% | -38.31% |
| 2020 | -56.70% | -59.53% | -53.14% |
| 2019 | -292.48% | -330.17% | -213.57% |
| 2018 | -112.23% | -124.05% | -111.54% |
| 2017 | -86.16% | -85.81% | -78.95% |
| 2016 | -152.64% | -153.16% | -141.19% |
| 2015 | -118.91% | -119.35% | -102.20% |
| 2014 | -76.38% | -76.52% | -69.84% |
Related Metrics
Explore detailed financial metrics and analysis for TNXP.